Company
Strand Tx
Building the Next Era of Genetic Medicine
Also known as Strand Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Boston, United States
- strandtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Strand is a clinical-stage biotechnology company with a pipeline of breakthrough mRNA therapeutics for cancers and autoimmune diseases.
Funding snapshot
- Total raised
- $302MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $153M2025-08-07
Funding rounds
- Series B
- $153M2025-08-07, Company stated
- Round, 2025
- $108M2025-05-23, SEC form D sold, 10 investors
- Series A
- $97M2022-11-28, Company stated
- Grant
- 2021-08-04
- Series A
- $52M2021-06-23, Company stated
- Round, 2021
- $52.1M2021-05-28, SEC form D sold, 13 investors
- Round, 2019
- $5.9M2019-05-24, SEC form D sold, 11 investors
Loading relationship preview